During the COVID-19 pandemic, therapeutic development took a backseat to vaccines – a potentially disastrous gamble had vaccines not been found. In future pandemics, therapeutics and vaccines should be treated equally – particularly as COVID-19 treatment options remain expensive and mostly only available in high-income countries, speakers told at a webinar this week hosted by […] Continue reading ->
CAPE TOWN – Moderna tried to extract a huge price for its COVID-19 vaccine from the South African government at the height of the pandemic, according to the local NGO, Health Justice Initiative (HJI), in revelations made public this week. The US-based pharma company wanted to charge $42 per vaccine in mid-2021 when vaccines were […] Continue reading ->
Health stories are not just about medical facts; they are intricate tapestries woven with economic, political, and social threads, according to two international health journalists. Stephanie Nolen, a global health reporter for The New York Times, and Paul Adepoju, a Nigeria-based freelance health journalist and scientist who writes for Health Policy Watch, were guests on […] Continue reading ->
The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading ->
Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure.    The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading ->
There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading ->